The more you think about the timing, the TITLE, and the non-issue content of Spencer's latest article, the more you would question his intent and his so-called "long position" of Arena Pharmaceuticals stock. ARNA is just beginning to form a bottom and starting to perk up, and then Spencer "desperately comes out with an article" to scuttle the rally. He shamelessly claimed that his previous reports on Arena's script #s had something to do with ARNA pps going down to $4ish, and now he can claim that his latest act had a direct effect on ARNA missing the market rally on Friday. You really have to wonder which side he is on.
On 12/18/2014 six key executives of Arena Pharm excercised their stock options at $5.52, totalling half a million shares. That included CEO and CFO. The insiders are confident that ARNA share price will go up. The know more about their business than anyone else. Stay tuned for upbeat news.
Correct. Longs are not selling. The idiot short sellers are selling hard to push the price down. I have my buy orders waiting in line, 10,000 shares waiting to be filled.
I want to buy but am worried about the fact that institution ownership of Hilton is a pitiful of 0.12%, whereas the short ratio is 1.42%. That really scares me.
The institutions might have sold thier IPO shares to retail investors, and that could explain why HLT PPS has been range bound since IPO. More volilatiy ahead? Just wondering….
That's because VNDA is way overpriced and their drugs have pitiful market. Unlike VNDA, IGXT is way under-valued and their film will be very popular. I know that because I used mint-flavored film and love the fast absorption.
I believe we do have institutions backing for this stock. ARGS was better priced for IPO than so many other bio stock IPOs. It has a promising pipeline. The stock is a keeper.
ARNA has many near-term catalysts, already making a move. Check it out.
I would skip OCRX, too pricy and results will be years away.
While you are waiting and watching CHTP, why not pick up some shares of ARNA. Their FDA approved diet drug are gaining in sales and the company is getting more and more milestone payments, etc.